TAVR for All? The Surgical Perspective
JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE(2022)
摘要
In spite of the noninferiority of transcatheter aortic valve replacement (TAVR) in high- and intermediate-risk patients, there are still obstacles that need to be overcome before the procedure is further expanded and clinically integrated. The lack of evidence on the long-term durability of the bioprostheses used for TAVR remains of particular concern. In addition, surgery may be preferred over TAVR in patients with bicuspid aortic valve (BAV) or with concomitant pathologies such as other valve diseases (mitral regurgitation/tricuspid regurgitation), aortopathy, and coronary artery disease. In this review, we discuss and summarize relevant data from clinical trials, current trends, and remaining obstacles, and provide our perspective on the indications for the expansion of TAVR.
更多查看译文
关键词
aortic valve stenosis, transcatheter aortic valve replacement (TAVR), transcatheter aortic valve implantation (TAVI), surgical aortic valve replacement (SAVR), low risk, intermediate risk, high risk
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要